Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

============================================================

Monday, November 11, 2013

Negative News from the FDA for a hopeful MS drug

Sanofi Multiple Sclerosis Drug May Have Too Many Risks (4)
November 08, 2013


Sanofi’s multiple sclerosis treatment Lemtrada may not offer enough benefit to patients to outweigh risks including cancer, U.S. regulators said. Securities linked to the drug’s success plummeted.
Lemtrada’s “serious and potentially fatal safety issues,” which include the risk of autoimmune and thyroid diseases, may make the medicine too dangerous to approve unless there is substantial clinical benefit shown, Food and Drug Administration staff said in a report today. Agency reviewers also questioned whether Sanofi conducted adequate trials to prove the annual infusion works.
“That’s like a death sentence,” said Fabian Wenner, an analyst with Kepler Cheuvreux in Zurich, “It isn’t what everyone expected, an issue with the safety. It seems to be a more fundamental issue here.”

……..

To comment - click the comment link shown below
…….
USE OUR SHARE LINKS at the top of this page  - to provide this article to others
……
REMAIN up to date with MS News and Education
Visit: www.msviewsandnews.org  to register
…………………….
.

2 comments:

mikeDee said...

Yes it is disappointing for those with active RRMS. I have been on Lemtrada since 2010 and must say it is a fantastic therapy. I must have monthly blood tests for a 4 year period. I'm coming close to the end of this period and no reports or even suggestions of any issues with my general health. I do hope it will be approved.

mikeDee said...

Yes it is disappointing for those with active RRMS. I have been on Lemtrada since 2010 and must say it is a fantastic therapy. I must have monthly blood tests for a 4 year period. I'm coming close to the end of this period and no reports or even suggestions of any issues with my general health. I do hope it will be approved.